Market closed
Medtronic/$MDT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medtronic
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Ticker
$MDT
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Galway, Ireland
Employees
95,000
ISIN
IE00BTN1Y115
Website
Medtronic Metrics
BasicAdvanced
$109B
26.03
$3.27
0.81
$2.80
3.29%
Price and volume
Market cap
$109B
Beta
0.81
52-week high
$96.25
52-week low
$75.96
Average daily volume
7.1M
Dividend rate
$2.80
Financial strength
Current ratio
1.901
Quick ratio
1.186
Long term debt to equity
48.342
Total debt to equity
53.627
Dividend payout ratio (TTM)
84.62%
Interest coverage (TTM)
8.90%
Management effectiveness
Return on assets (TTM)
4.66%
Return on equity (TTM)
8.44%
Valuation
Price to earnings (TTM)
26.025
Price to revenue (TTM)
3.32
Price to book
2.21
Price to tangible book (TTM)
-30.2
Price to free cash flow (TTM)
20.163
Dividend yield (TTM)
3.29%
Forward dividend yield
3.29%
Growth
Revenue change (TTM)
2.72%
Earnings per share change (TTM)
3.82%
3-year revenue growth (CAGR)
1.46%
3-year earnings per share growth (CAGR)
-3.41%
3-year dividend per share growth (CAGR)
4.14%
What the Analysts think about Medtronic
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Medtronic stock.
Medtronic Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Medtronic Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Medtronic News
AllArticlesVideos
Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings
Seeking Alpha·9 hours ago
Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF
GlobeNewsWire·2 weeks ago
4 of Our Favorite Dividend Aristocrats Offer a Lifetime of Secure Passive Income
24/7 Wall Street·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Medtronic stock?
Medtronic (MDT) has a market cap of $109B as of May 14, 2025.
What is the P/E ratio for Medtronic stock?
The price to earnings (P/E) ratio for Medtronic (MDT) stock is 26.03 as of May 14, 2025.
Does Medtronic stock pay dividends?
Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is $2.8 and the yield is 3.29%. Medtronic has a payout ratio of 84.62% on a trailing twelve-month basis.
When is the next Medtronic dividend payment date?
The next Medtronic (MDT) dividend payment date is unconfirmed.
What is the beta indicator for Medtronic?
Medtronic (MDT) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.